the Effectiveness and Safety Study on Apatinib Combined With Vinorelbine Used for Driver Gene Mutation Negative Third-line and Third-line Post Progression Advanced Non-small Cell Lung Cancer
Phase of Trial: Phase II
Latest Information Update: 01 Feb 2019
At a glance
- Drugs Rivoceranib (Primary) ; Vinorelbine (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 28 Jan 2019 Phase has been changed from phase1 to phase2.
- 28 Jan 2019 Planned number of patients changed from 32 to 30.
- 23 Jan 2019 Planned End Date changed from 1 Jun 2019 to 1 Jun 2020.